Recursion CEO Najat Khan Withholds 80,498 Shares for Taxes

What Happened

• Najat Khan, CEO, President and a director of Recursion Pharmaceuticals (RXRX), had 80,498 shares withheld by the company to satisfy tax withholding obligations tied to the net settlement of restricted stock units (RSUs). The withheld shares are reported as disposed at $3.16 per share, totaling $254,374.

Key Details

• Transaction date: 2026-08-17; filing date: 2026-08-18 (Form 4) — appears timely.
• Price reported: $3.16 per share; total value shown: $254,374.
• Shares withheld/ disposed: 80,498 (transaction code F — payment of exercise price or tax liability).
• Footnote: F1 — issuer withheld shares to satisfy tax withholding for net-settled RSUs.
• Shares owned after transaction: Not specified in the provided filing excerpt.

Context

• This was an administrative tax-withholding action related to RSU net settlement (issuer withheld shares), not an open-market sale — a routine occurrence and not necessarily a signal about the insider’s view of the stock.
• Transaction code F denotes payment of tax liabilities/exercise price; for RSUs, net settlement means fewer shares are delivered to the insider because some are retained to cover taxes.